Erasing injury-related cortical synaptic potentiation as a new treatment for chronic pain

Department of Physiology, Faculty of Medicine, Center for the Study of Pain, University of Toronto, Medical Science Building, Room no. 3342, 1 King's College Circle, Toronto, Ontario, M5S 1A8, Canada.
Journal of Molecular Medicine (Impact Factor: 4.74). 05/2011; 89(9):847-55. DOI: 10.1007/s00109-011-0768-9
Source: PubMed

ABSTRACT Synaptic plasticity in the spinal cord and the cortex is believed to be important for the amplification of painful information in chronic pain conditions. The investigation of molecular mechanism responsible for maintaining injury-related plastic changes, such as through the study of long-term potentiation in these structures, provides potential novel targets for designing new medicine for chronic pain. Recent studies using integrative neurobiological approaches demonstrate that protein kinase M zeta (PKMζ) maintains pain-induced persistent changes in the anterior cingulate cortex (ACC), and inhibiting PKMζ by ζ-pseudosubstrate inhibitory peptide produces analgesic effects in animal models of chronic pain. We propose that targeting PKMζ, or its up- or downstream signaling proteins, in the ACC may provide novel clinical treatment for chronic pain.

Download full-text


Available from: Xiangyao Li, Oct 06, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Extracting meaningful and understandable knowledge from a trained neural network is one of the ultimate goals in the area of data mining. In this paper, we propose a technique for extracting knowledge with less complex mathematical elaboration based on our activation interval projection on each dimensional axis with certainty factor refinement. The knowledge is captured in forms of if-then rules which their premises are the conjunction of input feature intervals. Our experiment signifies that the extracted rules are accurate when compared with those from a neural network
    Neural Networks, 2002. IJCNN '02. Proceedings of the 2002 International Joint Conference on; 02/2002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Animal models of chronic pain are widely used to investigate basic mechanisms of chronic pain and to evaluate potential novel drugs for treating chronic pain. Among the different criteria used to measure chronic pain, behavioral responses are commonly used as the end point measurements. However, not all chronic pain conditions can be easily measured by behavioral responses such as the headache, phantom pain and pain related to spinal cord injury. Here I propose that cortical indexes, that indicate neuronal plastic changes in pain-related cortical areas, can be used as endpoint measurements for chronic pain. Such cortical indexes are not only useful for those chronic pain conditions where a suitable animal model is lacking, but also serve as additional screening methods for potential drugs to treat chronic pain in humans. These cortical indexes are activity-dependent immediate early genes, electrophysiological identified plastic changes and biochemical assays of signaling proteins. It can be used to evaluate novel analgesic compounds that may act at peripheral or spinal sites. I hope that these new cortical endpoint measurements will facilitate our search for new, and more effective, pain medicines, and help to reduce false lead drug targets.
    Molecular Pain 07/2011; 7:54. DOI:10.1186/1744-8069-7-54 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Long-term potentiation of synaptic strength (LTP) in nociceptive pathways shares principle features with hyperalgesia including induction protocols, pharmacological profile, neuronal and glial cell types involved and means for prevention. LTP at synapses of nociceptive nerve fibres constitutes a contemporary cellular model for pain amplification following trauma, inflammation, nerve injury or withdrawal from opioids. It provides a novel target for pain therapy. This review summarizes recent progress which has been made in unravelling the properties and functions of LTP in the nociceptive system and in identifying means for its prevention and reversal.
    Current Opinion in Pharmacology 11/2011; 12(1):18-27. DOI:10.1016/j.coph.2011.10.018 · 4.23 Impact Factor
Show more